Clinical trial Recruiting at 1 site Observational Ages 65 and up

Investigating BPPV in Elderly Patients in Primary Care

Official title: Screening for Benign Paroxysmal Positional Vertigo in Primary Care Among Elderly Presenting With Dizziness, Imbalance, and Increased Tendency to Fall

Run by Region Stockholm · NCT06643702 · Data updated 2026-11-12

This study is testing if simple balance tests for dizziness in older adults can help find hidden cases of BPPV and improve their quality of life while reducing their fall risk.

Quick facts

Study typeObservational
Ages65 Years and up
SexAll
Enrollment115 (estimated)
SponsorRegion Stockholm
Government
Locations1 site (Saltsjö-Boo, Stockholm County)
StatusRecruiting
StartedOctober 16, 2024
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedOctober 28, 2024
Trial IDNCT06643702 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are elderly patients aged 65 and older who present with dizziness, imbalance, or a history of falls.

Probably not a fit

Patients with conditions that contraindicate head and neck movements or those not meeting the inclusion criteria may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to determine if routine positional tests should be conducted on elderly patients (65 years and older) who visit primary care with symptoms of dizziness, imbalance, or increased fall risk. It focuses on identifying 'hidden' cases of Benign Paroxysmal Positional Vertigo (BPPV) that may not present with typical symptoms. By assessing the benefits of clinical screening and initial treatment for BPPV, the study seeks to improve the quality of life for elderly patients and reduce their risk of falls.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnosis and management of BPPV in the elderly, enhancing their quality of life and reducing fall-related injuries.

How similar studies have gone: While there is limited data on similar studies, the approach of screening for BPPV in elderly populations has shown promise in improving outcomes in related research.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Patients aged 65 years or older and present to the primary care clinic with one or several of the following:

1. Acute, episodic, or chronic sensation of dizziness/vertigo.
2. Subjective or objective imbalance during stance or movements.
3. Presented with increased tendency of falls by exhibiting unintentional loss of balance resulting in a fall one or more times in the past 12 months.

Exclusion Criteria:

1. Patients not meeting the above epidemiological and medical criteria described under "Inclusion Criteria".
2. Patients presenting with pathologies in which head and neck movements/manipulations are contraindicated, including (but not limited to): cervical instability, acute head and neck trauma, known cervical disk prolapse, Arnold-Chiari malformation, vascular pathologies such as carotid sinus syncope, vascular dissection and vertebrobasilarinsufficiency, including patients with paralysis as well as those with reduced mobility, in whom diagnostic maneuvers cannot be correctly performed.

Where it's running

  • Boo health center
    Saltsjö-Boo, Stockholm County, Sweden
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.